Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis.

Data Brief. 2019 Dec;27:104415

Authors: Vázquez-Bourgon J, Ortiz-García de la Foz V, Suarez-Pereira I, Iruzubieta P, Arias-Loste MT, Setién-Suero E, Ayesa-Arriola R, Gómez-Revuelta M, Crespo J, Crespo Facorro B

The presented article describes data from secondary analyses, related to the research article entitled « Cannabis consumption and Non-Alcoholic Fatty Liver Disease. A three years longitudinal study in first episode non-affective psychosis patients » [1]. We present detailed data regarding the socio-demographic and baseline clinical characteristics of a sample of 390 drug-naïve patients with a first episode of non-affective psychosis, and the differences between cannabis users and non-users in those characteristics. Tables also show the results from cross-sectional and longitudinal statistical analyses exploring the relation between cannabis consumption and liver function, after excluding those patients with hazardous alcohol drinking.

PMID: 31737751 [PubMed]

Source: ncbi 2

Partage le savoir
Categories: Medical

error: Content is protected !!